Bio-Techne Corp Price Today
Bio-Techne Corp
TECH
Healthcare
$10.72B
💰
Market Cap
49.1
💸
Price to Earnings
$1.4
🎉
EPS
+45
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
9 |
Strong Buy |
8 |
Hold |
3 |
Sell |
0 |
Strong Sell |
0 |
TECH Price Forecast Target
68.2 👉 95.0 +39%
TECH EPS Forecast
1.4 👉 2.0 +45%
Financials
Profit Margin
20 %
Revenue Growth
0.4 %
Dividend
$ 0.32
Held Percent
1.0% - Insiders
100.5% - Institutions
-1.5% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $1.2B
-
💰 Blackrock Inc. $1.2B
-
💰 State Street Corporation $431.7M
-
💰 BAMCO Inc. $365.1M
-
💰 Select Equity Group, Inc. $311.0M
Stock Ideas
Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …📮FAQ
Some Frequently Asked Questions.
The Bio-Techne Corp industry is Biotechnology
The Bio-Techne Corp sector is Healthcare
The Bio-Techne Corp forecasted predicted Price to Earnings PE ratio is 33.9
The Bio-Techne Corp Price to Earnings PE ratio is 49.1
The Market Capitalization of Bio-Techne Corp is $10.72B
There are total of 155394984 float shares with 100.5% held by Institutions and 1.0% held by insiders
The MBio-Techne Corp forecasted Earnings per Share EPS is $2.0
The Bio-Techne Corp Earnings per Share EPS is 1.4
The Bio-Techne Corp company has $0 gross profits with 20 profit margins
The Bio-Techne Corp Earnings Growth is -0.452% with -0.451% quarterly earnings growth
The Bio-Techne Corp Revenue is $1144999040 with 0.004 revenue growth
The price target for Bio-Techne Corp stock is $95.0 for the high target and $65.0 for the low target
The consensus analyst recommendations for Bio-Techne Corp is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bio-Techne Corp is Buy, with the following breakdown:
- Buy: 9
- Strong Buy: 8
- Hold: 3
- Sell: 0
- Strong Sell: 0
The Beta of Bio-Techne Corp is 1.2
The dividend of Bio-Techne Corp is $0.32
The dividend yield of Bio-Techne Corp is 0.0047%
The biggest institutional and mutual fund holders of Bio-Techne Corp stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- BAMCO Inc.
The Bio-Techne Corp ESG Score is 45, with the following breakdown:
- E: 56.89
- S: 56.41
- G: 48.85